OXYTROL

This brand name is authorized in Australia, Canada, New Zealand, United States

Active ingredients

The drug OXYTROL contains one active pharmaceutical ingredient (API):

1 Oxybutinin UNII K9P6MC7092 - OXYBUTYNIN

Oxybutynin acts as a competitive antagonist of acetylcholine at post-ganglionic muscarinic receptors, resulting in relaxation of bladder smooth muscle. Read about Oxybutinin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
OXYTROL Transdermal system	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G04BD04	Oxybutynin	G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BD Urinary antispasmodics
Discover more medicines within G04BD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 9454N
Country: CA	Health Products and Food Branch	Identifier(s): 02254735
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 12466
Country: US	FDA, National Drug Code	Identifier(s): 0023-6153